Banque Cantonale Vaudoise’s Beam Therapeutics BEAM Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$238K	Buy	+10,000	New	+$277K	0.01%	614
2022 Q3	–	Sell	-1,167	Closed	-$45K	–	1234
2022 Q2	$45K	Buy	1,167 +28	+2%	+$1.11K	﹤0.01%	1022
2022 Q1	$65K	Hold	1,139	–	–	﹤0.01%	993
2021 Q4	$91K	Hold	1,139	–	–	﹤0.01%	972
2021 Q3	$99K	Buy	1,139 +139	+14%	+$14K	﹤0.01%	935
2021 Q2	$129K	Hold	1,000	–	–	0.01%	919
2021 Q1	$80K	Hold	1,000	–	–	﹤0.01%	950
2020 Q4	$82K	Hold	1,000	–	–	﹤0.01%	873
2020 Q3	$25K	Buy	+1,000	New	+$24.8K	﹤0.01%	963

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Banque Cantonale Vaudoise's BEAM Position: Q1 2026 in Review

Banque Cantonale Vaudoise opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 10,000 shares worth $238K. The stake represents 0.01% of the portfolio and ranks #614 among its holdings. This is a return to the name: Banque Cantonale Vaudoise previously reported a position in BEAM as recently as Q2 2022.

Banque Cantonale Vaudoise first reported a position in BEAM in Q3 2020 and has held it in 9 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Banque Cantonale Vaudoise held 10,000 shares of Beam Therapeutics worth $238K as of Q1 2026.
Beam Therapeutics was a new Banque Cantonale Vaudoise position in Q1 2026.
Beam Therapeutics made up 0.01% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #614 holding.
Banque Cantonale Vaudoise first reported a position in Beam Therapeutics in Q3 2020 and has held it in 9 quarters since.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.